Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse (TIPA)

Institut de Cancérologie de la Loire

Status: Unknown

Conditions: Breast Neoplasms

Treatments: Other: Advanced Practice Nurse consultation

Study type: Interventional

Funder types: Other

Identifiers

NCT02686918

2016-01

Details and patient eligibility

About

The main of this study is to assess the feasibility of a patients follow-up visit receiving trastuzumab subcutaneous by Advanced Practice Nurse.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient care at the Cancer Institute Lucien Neuwirth
• Patient aged over 18 years
• Patient with breast cancer overexpressing HER2 adjuvant
• Patient having finished their chemotherapy treatment with IV followed the oncologist day hospital
• Patient under Trastzumab subcutaneously
• Patient affiliated or entitled to a social security scheme (mandatory requirement for all studies)

Exclusion criteria

• Refusal to participate, most patient protected under guardianship.
• Patient in inability to understand the course of the study
• Patient with documented history of cognitive or psychiatric disorders.
• Patients pregnant or lactating
• Patients under guardianship or curatorship

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

consultation by Advanced Practice Nurse.

Experimental group

Description:

During consultations, patients will be seen successively by Advanced Practice Nurse and referent oncologist.

Treatment:

Other: Advanced Practice Nurse consultation